Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage
This study has been completed.
Sponsor:
Planned Parenthood League of Massachusetts
Collaborator:
Society of Family Planning
Information provided by (Responsible Party):
Planned Parenthood League of Massachusetts
ClinicalTrials.gov Identifier:
NCT01595282
First received: May 19, 2011
Last updated: December 12, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this study is to compare the effect of pre-procedural ketorolac to ibuprofen on immediate post-procedural pain scores in patients undergoing first trimester suction curettage with local anesthesia only.
Our primary hypothesis is that IM ketorolac compared to oral ibuprofen will result in an approximate 30% reduction in pain scores on a 21-point numerical rating scale immediately after the procedure.
Secondary hypotheses include:
- Pain scores on the 21-point scale will also be significantly lower in the ketorolac group immediately after cervical dilation and 15 minutes post-procedure.
- Fewer patients in the ketorolac group will rate their pain as "severe" on a subjective pain rating scale.
- Patients in the ketorolac group will be more satisfied with their pain control.
- Side effects will be similar between groups.
| Condition | Intervention |
|---|---|
|
Pain |
Drug: Ketorolac Drug: Ibuprofen |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage: a Randomized Clinical Trial. |
Resource links provided by NLM:
Drug Information available for:
Ibuprofen
Ibuprofen sodium
Ibuprofen lysinate
Ketorolac
Ketorolac tromethamine
U.S. FDA Resources
Further study details as provided by Planned Parenthood League of Massachusetts:
Primary Outcome Measures:
- Immediate post-procedure pain score [ Time Frame: Immediately (within 1 minute) after suction and speculum removal ] [ Designated as safety issue: No ]The primary endpoint is subjects' immediate post-procedure pain score on a 21-point 0 to 100 scale (in increments of five). This scale has been previously validated and used for research purposes, including for pain research evaluating suction curettage elsewhere and at our institution (Jensen 1986, Williamson 2004, Allen 2009).
Secondary Outcome Measures:
- Pain scores immediately after cervical dilation [ Time Frame: Immediately (within 1 minute) after cervical dilation prior to the introduction of the suction cannula ] [ Designated as safety issue: No ]21-point 0 to 100 scale (in increments of five)
- Pain scores 15 minutes post-procedure [ Time Frame: Fifteen minutes after the procedure ] [ Designated as safety issue: No ]21-point 0 to 100 scale (in increments of five)
- Change in Subjective pain score [ Time Frame: immediately after cervical dilation, immediately after the procedure, and 15 minutes after the procedure ] [ Designated as safety issue: No ]We will measure pain on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
| Enrollment: | 94 |
| Study Start Date: | June 2011 |
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Ketorolac
Intramuscular injection of ketorolac 60 mg in 2cc -plus- placebo tablet (calcium carbonate 600 mg tablet). For subjects who are 50 kg or less, intramuscular injection of ketorolac 30 mg in 1cc -plus- placebo tablet (calcium carbonate 600 mg tablet)
|
Drug: Ketorolac
For subjects weighing over 50 kg, ketorolac 60 mg in 2cc administered via intramuscular injection 30-60 minutes before suction curettage procedure. For subjects weighing 50 kg or less, ketorolac 30 mg in 1 cc administered via intramuscular injection 30-60 minutes before suction curettage procedure
Other Name: Toradol
|
|
Active Comparator: Ibuprofen
Ibuprofen 800 mg tablet -plus- intramuscular injection of 2cc saline placebo. For subjects weighing 50 kg or less, ibuprofen 600 mg tablet -plus- intramuscular injection of 2cc saline placebo
|
Drug: Ibuprofen
For subjects weighing over 50 kg, ibuprofen 800 mg tablet administered orally 60-90 minutes before suction curettage procedure. For subjects weighing 50 kg or less, ibuprofen 600 mg tablet administered orally 60-90 minutes before suction curettage procedure.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Women age 18 or older seeking suction curettage at Planned Parenthood League of Massachusetts (PPLM)
- Gestational age less than or equal to 11+6, confirmed by ultrasound
- Eligible for suction curettage according to PPLM protocols
- Choice of local anesthesia
Exclusion Criteria:
- Choice of IV sedation for pain control
- Hypersensitivity to NSAIDs or lidocaine
- Contraindications to NSAIDs:
Active renal disease Active hepatic disease Gastric ulcer disease or gastritis Long-term NSAID or aspirin use Bleeding disorder
- NSAIDs taken < 8 hours prior to procedure
- Need for cervical ripening with either misoprostol or mechanical priming agent (laminaria/Dilapan)
- Long-term narcotic use
- Unable or unwilling to complete required study procedures
- Previous participation in the study
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01595282
Locations
| United States, Massachusetts | |
| Planned Parenthood League of Massachusetts | |
| Boston, Massachusetts, United States, 02215 | |
Sponsors and Collaborators
Planned Parenthood League of Massachusetts
Society of Family Planning
Investigators
| Principal Investigator: | Principal Investigator, MD, MPH | Planned Parenthood League of Massachusetts |
More Information
No publications provided
| Responsible Party: | Planned Parenthood League of Massachusetts |
| ClinicalTrials.gov Identifier: | NCT01595282 History of Changes |
| Other Study ID Numbers: | 2011-p-000259 |
| Study First Received: | May 19, 2011 |
| Last Updated: | December 12, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Planned Parenthood League of Massachusetts:
|
pain suction curettage |
Additional relevant MeSH terms:
|
Ibuprofen Ketorolac Ketorolac Tromethamine Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Pharmacologic Actions Anti-Inflammatory Agents Therapeutic Uses Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Central Nervous System Agents |
ClinicalTrials.gov processed this record on May 19, 2013